chr2-50346870-GCGCCGCCGCCGCCGC-G

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001330092.2(NRXN1):​c.65_79delGCGGCGGCGGCGGCG​(p.Gly22_Gly26del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00361 in 1,366,786 control chromosomes in the GnomAD database, including 340 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 38 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 302 hom. )

Consequence

NRXN1
NM_001330092.2 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.96
Variant links:
Genes affected
NRXN1 (HGNC:8008): (neurexin 1) This gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3,000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for this gene in the 3' region. Mutations in this gene are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 2-50346870-GCGCCGCCGCCGCCGC-G is Benign according to our data. Variant chr2-50346870-GCGCCGCCGCCGCCGC-G is described in ClinVar as [Benign]. Clinvar id is 287918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0652 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NRXN1NM_001330078.2 linkuse as main transcriptc.3365-109915_3365-109901delGCGGCGGCGGCGGCG intron_variant ENST00000401669.7 NP_001317007.1 E7ERL8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NRXN1ENST00000401669.7 linkuse as main transcriptc.3365-109915_3365-109901delGCGGCGGCGGCGGCG intron_variant 5 NM_001330078.2 ENSP00000385017.2 E7ERL8

Frequencies

GnomAD3 genomes
AF:
0.0146
AC:
2202
AN:
150380
Hom.:
38
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0489
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00523
Gnomad ASJ
AF:
0.00696
Gnomad EAS
AF:
0.00412
Gnomad SAS
AF:
0.000623
Gnomad FIN
AF:
0.0000998
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000460
Gnomad OTH
AF:
0.0145
GnomAD3 exomes
AF:
0.00797
AC:
597
AN:
74950
Hom.:
196
AF XY:
0.00662
AC XY:
293
AN XY:
44242
show subpopulations
Gnomad AFR exome
AF:
0.196
Gnomad AMR exome
AF:
0.0111
Gnomad ASJ exome
AF:
0.0133
Gnomad EAS exome
AF:
0.0140
Gnomad SAS exome
AF:
0.000166
Gnomad FIN exome
AF:
0.0000876
Gnomad NFE exome
AF:
0.00116
Gnomad OTH exome
AF:
0.00378
GnomAD4 exome
AF:
0.00224
AC:
2726
AN:
1216306
Hom.:
302
AF XY:
0.00204
AC XY:
1216
AN XY:
594990
show subpopulations
Gnomad4 AFR exome
AF:
0.0679
Gnomad4 AMR exome
AF:
0.00750
Gnomad4 ASJ exome
AF:
0.00948
Gnomad4 EAS exome
AF:
0.00257
Gnomad4 SAS exome
AF:
0.000515
Gnomad4 FIN exome
AF:
0.000179
Gnomad4 NFE exome
AF:
0.000357
Gnomad4 OTH exome
AF:
0.00479
GnomAD4 genome
AF:
0.0147
AC:
2205
AN:
150480
Hom.:
38
Cov.:
32
AF XY:
0.0141
AC XY:
1038
AN XY:
73468
show subpopulations
Gnomad4 AFR
AF:
0.0488
Gnomad4 AMR
AF:
0.00523
Gnomad4 ASJ
AF:
0.00696
Gnomad4 EAS
AF:
0.00414
Gnomad4 SAS
AF:
0.000624
Gnomad4 FIN
AF:
0.0000998
Gnomad4 NFE
AF:
0.000460
Gnomad4 OTH
AF:
0.0144
Bravo
AF:
0.0164

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 02, 2016- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 21, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
NRXN1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 15, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs750165040; hg19: chr2-50574008; API